Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Combined formulation for treating inflammatory bowel diseases

An inflammatory bowel disease and formula technology, applied in drug combination, pharmaceutical formula, allergic diseases and other directions, can solve problems such as unsatisfactory effect and large side effects, and achieve the effect of prolonging human lifespan, good therapeutic effect, and enhancing blood supply.

Inactive Publication Date: 2016-04-13
何松庆
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above-mentioned treatment measures are unsatisfactory and have large side effects. Therefore, it is an urgent task for the medical community to study the etiology of inflammatory bowel disease, find the cause of the disease, and take corresponding treatment measures.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] 1. Ganoderma lucidum 0.5 grams, Salvia miltiorrhiza 0.6 grams, glutamine 1.2 grams, threonine 0.5 grams, serine 0.6 grams, cysteine ​​0.06 grams, vitamin C 50 mg, vitamin E 4 mg, vitamin A 0.1 mg, β-carrot Su 0.6 mg is made into a chewable agent, 2 to 4 times a day.

[0028] 2. Ganoderma lucidum 0.25g, Salvia miltiorrhiza 0.3g, glutamine 0.6g, threonine 0.25g, serine 0.3g, cysteine ​​0.03g, vitamin C 25mg, vitamin E 2mg, vitamin A 0.05mg, β-carrot Su 0.3 mg is made into a chewing agent, 2 to 4 times a day.

[0029] 3. Ganoderma lucidum 0.5g, Salvia miltiorrhiza 0.6g, glutamine 1.2g, threonine 0.5g, serine 0.6g, cysteine ​​0.06g, vitamin C50mg, vitamin E4mg, vitamin A0.1mg, β-carrot Su 0.6 mg is made into a dose, 2 to 4 times a day.

[0030] 4. Ganoderma lucidum 0.25g, Salvia miltiorrhiza 0.3g, glutamine 0.6g, threonine 0.25g, serine 0.3g, cysteine ​​0.03g, vitamin C 25mg, vitamin E 2mg, vitamin A 0.05mg, β-carrot Su 0.3 mg is made into a dose, 2 to 4 times a day.

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a combined formulation for treating inflammatory bowel diseases and belongs to the field of medicine. The combined formulation is composed of Ganoderma lucidum, Salvia miltiorrhiza, glutamine, threonine, serine cysteine, vitamins C, E and A and beta-carotene. Ganoderma lucidum and Salvia miltiorrhiza have efficacy of enhancing human blood supply and oxygen supply, glutamine is a main energy source of intestinal mucosa, threonine, serine and cysteine are main components of mucoprotein, and the vitamins C, E and A and beta-carotene has effects of inhibiting oxygen radical activity, eliminating oxygen radicals and protecting human cells. The combined formulation provides nutrition, oxygen and raw materials for generation, updating and restoring of goblet cells and to the goblet cells to secrete mucoprotein to form intestinal tract surface mucous layer barriers. The combined formulation has obvious effect on stopping inflammation, restoring intestinal tract tissue and building normal human intestinal tract surface mucous layer barriers and is an effective composition for treating the inflammatory bowel diseases.

Description

technical field [0001] The invention relates to a combination formula of Chinese medicinal materials, amino acids and vitamins for treating inflammatory bowel disease, and belongs to the field of medicines. Background technique [0002] Inflammatory bowel disease (inflammatory bowel disease, IBD) is a disease whose etiology and pathogenesis have not yet been fully clarified. Because the cause of the disease and the pathogenesis have not been fully elucidated, people cannot fundamentally prevent or delay the progress of the disease. [0003] Medical immunology believes that the immune system has abnormal recognition and tolerance to antigens, that is, it produces an immune response to the abnormal recognition of normal intestinal microorganisms, causing the disease. Histology and embryology believe that the high permeability of the intestinal mucosa leads to a large number of intestinal antigens entering the intestinal wall tissue, triggering a long-term response of the immu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/537A61P1/00A61P31/00A61P1/12A61P11/06A61P11/02A61P37/08A61K31/198A61K31/375A61K31/355A61K31/07A61K31/015
CPCA61K9/0053A61K9/0056A61K31/015A61K31/07A61K31/198A61K31/355A61K31/375A61K36/074A61K36/537A61K2300/00
Inventor 何松庆
Owner 何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com